• Understanding the needs and perspectives of ovarian cancer patients when considering PARP inhibitor maintenance therapy: Findings from two online community events.
    • Monuszko KA, Fish LJ, Sparacio D, Lizaso C, Burn K, Wickenheisser N, Meyer LA, Reed SD, Davidson BA, Havrilesky LJ.
    • Gynecol Oncol Rep. 2022 Jul 26;101050. doi: 10.1016/j.gore.2022.101050.